Mologen To Pursue Combinations Only After Lefitolimod’s Solo IMPALA Failure

 
• By Sten Stovall
  
Dart
Mologen ends monotherapy approach for lefitolimod after Phase III failure • Source: Shutterstock

More from Clinical Trials

More from R&D